Lack of venture capital in the US keeps new nanotechnology products away from the market. Read the article at Berlingske
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
A collaboration between Medicon Valley Alliance and Invest in Skåne has been established to create a more attractive research environment in the Medicon Valley region. Published in Dagens Industri
Invest in Skåne and the cluster organisation Medicon Valley Alliance have been granted DKK 14.5 million from the EU Interreg IV.
The collaboration between MassBio and Medicon Valley Alliance (MVA) established as a part of the Life Science Ambassador Program opens up a number of MassBio services that can be utilized by members of MVA.
LEO Pharma has embarked on an ambitious strategy with a long term view on strategies and structures.
With health care facing major challenges in every country in the world, learning from other countries’ experiences is key.
Nano Connect Scandinavia and Medicon Valley Alliance invites you to join a partnering mission in January 2012 to the two most interesting nanomedicine clusters in the U.S, North Carolina and Massachusetts.
One of the focus areas for the Life Science Ambassador Program (LSAP) is to help SMEs in their internationalization efforts. Recently, EXINI signed a very lucrative contract with FUJIFILM Pharma for the licensing of their EXINI Bone technology in Japan.
Torsten Jepsen is the newly appointed Life Science Ambassador. He is based in one of the world’s leading life science clusters, Boston-Cambridge, Massachusetts, US.